Glaukos Corporation (GKOS)
NYSE: GKOS · Real-Time Price · USD
96.56
+1.44 (1.51%)
At close: Aug 28, 2025, 4:00 PM
96.56
0.00 (0.00%)
After-hours: Aug 28, 2025, 7:00 PM EDT
Glaukos Employees
Glaukos had 995 employees as of December 31, 2024. The number of employees increased by 88 or 9.70% compared to the previous year.
Employees
995
Change (1Y)
88
Growth (1Y)
9.70%
Revenue / Employee
$435,129
Profits / Employee
-$93,258
Market Cap
5.54B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 995 | 88 | 9.70% |
Dec 31, 2023 | 907 | 124 | 15.84% |
Dec 31, 2022 | 783 | 56 | 7.70% |
Dec 31, 2021 | 727 | 74 | 11.33% |
Dec 31, 2020 | 653 | 53 | 8.83% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
GKOS News
- 15 days ago - Glaukos Announces Participation in Wells Fargo Healthcare Conference - Business Wire
- 4 weeks ago - Glaukos Corporation (GKOS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Glaukos Announces Second Quarter 2025 Financial Results - Business Wire
- 7 weeks ago - Glaukos to Release Second Quarter 2025 Financial Results after Market Close on July 30 - Business Wire
- 2 months ago - Glaukos Announces EU MDR Certification for iStent infinite® and Other Leading MIGS Therapies - Business Wire
- 2 months ago - Glaukos to Celebrate 10th Anniversary of IPO Listing with NYSE Closing Bell - Business Wire
- 3 months ago - Glaukos Announces Participation in Upcoming Investor Conferences - Business Wire
- 4 months ago - Glaukos Corporation (GKOS) Q1 2025 Earnings Call Transcript - Seeking Alpha